NCT00067639 - Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions

Multiple Myeloma

Interventions

DRUG

Pegfilgrastim (Neulasta)

12 mg single injection of pegfilgrastim under the skin prior to apheresis.

PROCEDURE

Apheresis

Collection of stem cells, repeated daily until target stem cell dose reached, maximum of 5 procedures.

Trial Locations (1)

MD Anderson Cancer Center, Houston